Challenges and Opportunities for Childhood Cancer Drug Development
Author:
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmacology,Molecular Medicine
Reference322 articles.
1. Lineage of origin in rhabdomyosarcoma informs pharmacological response
2. Drug discovery in paediatric oncology: roadblocks to progress
3. Adamson PC Weiner SL Simone JV Gelband H (2005) Making Better Drugs for Children with Cancer, National Academies Press, Washington, DC.
4. Phase I Study of the Anti-CD22 Antibody–Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
5. HER2-specific chimeric antigen receptor-modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial;Ahmed;JAMA Oncol,2017
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Population‐level 5‐year event‐free survival for children with cancer in Australia;Pediatric Blood & Cancer;2024-07-30
2. Off‐label prescribing of immune checkpoint inhibitor therapy at a single pediatric cancer center;Cancer Medicine;2024-04
3. Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children’s Hospital at Baylor College of Medicine;Biomedicines;2024-02-08
4. Practice of pediatric oncology drug development;Essentials of Translational Pediatric Drug Development;2024
5. Cytotoxic and antiproliferative effects of hellebrin on breast and lung cancer cells;Veteriner Hekimler Derneği Dergisi;2023-06-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3